| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 22 | 2020 | 944 | 2.360 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 5 | 2022 | 119 | 2.070 |
Why?
|
| Anabolic Agents | 5 | 2024 | 256 | 1.950 |
Why?
|
| Magnetic Resonance Spectroscopy | 16 | 2020 | 3678 | 1.700 |
Why?
|
| Xenon | 2 | 2025 | 120 | 1.360 |
Why?
|
| Brain | 44 | 2024 | 27179 | 1.320 |
Why?
|
| Testosterone Congeners | 3 | 2021 | 62 | 1.320 |
Why?
|
| Androgens | 6 | 2024 | 1278 | 1.310 |
Why?
|
| Cocaine-Related Disorders | 10 | 2019 | 458 | 1.020 |
Why?
|
| Tobacco Use Disorder | 5 | 2012 | 708 | 1.000 |
Why?
|
| Brain Chemistry | 7 | 2015 | 952 | 0.980 |
Why?
|
| Substance Withdrawal Syndrome | 4 | 2023 | 627 | 0.950 |
Why?
|
| Cues | 8 | 2024 | 876 | 0.910 |
Why?
|
| Morphine Dependence | 1 | 2023 | 27 | 0.880 |
Why?
|
| Opioid-Related Disorders | 7 | 2025 | 2177 | 0.860 |
Why?
|
| Saimiri | 9 | 2019 | 337 | 0.850 |
Why?
|
| Glutamic Acid | 5 | 2020 | 1181 | 0.780 |
Why?
|
| Putamen | 7 | 2011 | 288 | 0.670 |
Why?
|
| Smoking | 6 | 2012 | 9082 | 0.660 |
Why?
|
| Narcotics | 4 | 2023 | 333 | 0.660 |
Why?
|
| Drug-Seeking Behavior | 1 | 2019 | 45 | 0.630 |
Why?
|
| Gene Products, tat | 3 | 2015 | 111 | 0.620 |
Why?
|
| Substance-Related Disorders | 6 | 2024 | 4418 | 0.610 |
Why?
|
| Glycine | 5 | 2019 | 671 | 0.610 |
Why?
|
| Choline | 7 | 2020 | 511 | 0.590 |
Why?
|
| Acetylcysteine | 1 | 2019 | 262 | 0.580 |
Why?
|
| Gyrus Cinguli | 5 | 2020 | 1116 | 0.570 |
Why?
|
| Discrimination Learning | 1 | 2019 | 276 | 0.560 |
Why?
|
| Creatine | 5 | 2020 | 424 | 0.550 |
Why?
|
| Magnetic Resonance Imaging | 36 | 2024 | 36547 | 0.540 |
Why?
|
| Anesthetics, Inhalation | 2 | 2025 | 573 | 0.530 |
Why?
|
| Cognition | 6 | 2024 | 7043 | 0.520 |
Why?
|
| Caudate Nucleus | 7 | 2013 | 388 | 0.510 |
Why?
|
| Antimetabolites | 1 | 2016 | 128 | 0.500 |
Why?
|
| Extinction, Psychological | 2 | 2019 | 367 | 0.500 |
Why?
|
| Smoking Cessation | 4 | 2011 | 2084 | 0.500 |
Why?
|
| Deoxyglucose | 1 | 2016 | 322 | 0.490 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2019 | 543 | 0.460 |
Why?
|
| Tranquilizing Agents | 1 | 2014 | 59 | 0.460 |
Why?
|
| Dog Diseases | 1 | 2013 | 142 | 0.400 |
Why?
|
| Methadone | 4 | 2006 | 318 | 0.390 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2017 | 749 | 0.380 |
Why?
|
| Macaca fascicularis | 1 | 2013 | 908 | 0.360 |
Why?
|
| Image Processing, Computer-Assisted | 9 | 2017 | 8924 | 0.360 |
Why?
|
| Aspartic Acid | 5 | 2020 | 575 | 0.360 |
Why?
|
| Phosphorus | 2 | 2004 | 336 | 0.360 |
Why?
|
| Nucleus Accumbens | 1 | 2013 | 360 | 0.350 |
Why?
|
| Limbic System | 2 | 2013 | 418 | 0.350 |
Why?
|
| Suicide | 1 | 2021 | 1606 | 0.330 |
Why?
|
| Prefrontal Cortex | 5 | 2021 | 2223 | 0.330 |
Why?
|
| Animals | 37 | 2025 | 168735 | 0.320 |
Why?
|
| tau Proteins | 1 | 2019 | 2110 | 0.300 |
Why?
|
| Vasoconstriction | 3 | 2001 | 593 | 0.300 |
Why?
|
| Energy Metabolism | 3 | 2017 | 2894 | 0.300 |
Why?
|
| Receptors, Nicotinic | 1 | 2011 | 495 | 0.300 |
Why?
|
| Dopamine Uptake Inhibitors | 3 | 2019 | 287 | 0.290 |
Why?
|
| Primates | 2 | 2020 | 518 | 0.280 |
Why?
|
| Anisotropy | 3 | 2016 | 1284 | 0.280 |
Why?
|
| Basal Ganglia | 4 | 2004 | 549 | 0.280 |
Why?
|
| Memory | 2 | 2014 | 2191 | 0.280 |
Why?
|
| Phosphocreatine | 3 | 2020 | 259 | 0.280 |
Why?
|
| Brain Mapping | 5 | 2020 | 6598 | 0.270 |
Why?
|
| Weight Lifting | 2 | 2024 | 130 | 0.260 |
Why?
|
| Inositol | 2 | 2019 | 215 | 0.260 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2019 | 896 | 0.250 |
Why?
|
| Receptors, Serotonin | 3 | 1996 | 209 | 0.250 |
Why?
|
| Fear | 1 | 2014 | 1496 | 0.250 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 3892 | 0.250 |
Why?
|
| Blood Volume | 5 | 2004 | 544 | 0.240 |
Why?
|
| Cerebrovascular Circulation | 7 | 2004 | 2674 | 0.240 |
Why?
|
| Cognition Disorders | 3 | 2015 | 3965 | 0.230 |
Why?
|
| Cerebellum | 3 | 2007 | 1519 | 0.230 |
Why?
|
| Dementia | 1 | 2019 | 2741 | 0.230 |
Why?
|
| Heroin Dependence | 2 | 2004 | 174 | 0.220 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2013 | 1485 | 0.220 |
Why?
|
| Male | 61 | 2024 | 363815 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 3 | 2013 | 4394 | 0.210 |
Why?
|
| Injections, Intravenous | 8 | 2013 | 1376 | 0.210 |
Why?
|
| Doxycycline | 3 | 2015 | 348 | 0.210 |
Why?
|
| Receptors, Drug | 3 | 1991 | 156 | 0.210 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 3834 | 0.210 |
Why?
|
| Choroid Plexus | 3 | 1996 | 249 | 0.200 |
Why?
|
| Alcohol-Related Disorders | 1 | 2025 | 242 | 0.200 |
Why?
|
| Adult | 47 | 2024 | 223088 | 0.200 |
Why?
|
| Hypertrophy | 2 | 2015 | 562 | 0.200 |
Why?
|
| Nitrogen | 1 | 2023 | 344 | 0.200 |
Why?
|
| Demyelinating Diseases | 1 | 2004 | 355 | 0.190 |
Why?
|
| Oxygen | 6 | 2023 | 4246 | 0.190 |
Why?
|
| HIV Infections | 3 | 2022 | 17531 | 0.190 |
Why?
|
| Wales | 1 | 2021 | 87 | 0.180 |
Why?
|
| Self Administration | 2 | 2019 | 386 | 0.180 |
Why?
|
| Neuropsychological Tests | 4 | 2024 | 7116 | 0.180 |
Why?
|
| Naltrexone | 1 | 2023 | 319 | 0.180 |
Why?
|
| Neural Pathways | 3 | 2020 | 3087 | 0.180 |
Why?
|
| Ethanol | 3 | 1998 | 1325 | 0.180 |
Why?
|
| Pyrrolidines | 2 | 2013 | 337 | 0.180 |
Why?
|
| Methylphenidate | 1 | 2004 | 480 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2020 | 10727 | 0.170 |
Why?
|
| Humans | 63 | 2025 | 765926 | 0.170 |
Why?
|
| Autoradiography | 7 | 2006 | 723 | 0.170 |
Why?
|
| Dogs | 2 | 2017 | 3824 | 0.170 |
Why?
|
| Attention | 1 | 2010 | 2413 | 0.170 |
Why?
|
| Nerve Net | 1 | 2012 | 2310 | 0.170 |
Why?
|
| Crime | 1 | 2021 | 206 | 0.170 |
Why?
|
| England | 1 | 2021 | 533 | 0.160 |
Why?
|
| Glycine Dehydrogenase (Decarboxylating) | 1 | 2019 | 15 | 0.160 |
Why?
|
| Glycine Agents | 1 | 2019 | 16 | 0.160 |
Why?
|
| Morphine | 1 | 2023 | 660 | 0.160 |
Why?
|
| Animals, Genetically Modified | 2 | 2015 | 1563 | 0.160 |
Why?
|
| Dopamine | 3 | 2019 | 1582 | 0.160 |
Why?
|
| Republic of Korea | 1 | 2021 | 583 | 0.160 |
Why?
|
| Alcoholism | 3 | 2025 | 1978 | 0.160 |
Why?
|
| Phosphatidylinositols | 3 | 1996 | 275 | 0.150 |
Why?
|
| Narcotic Antagonists | 1 | 2023 | 590 | 0.150 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2020 | 2415 | 0.150 |
Why?
|
| Free Radical Scavengers | 1 | 2019 | 213 | 0.150 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2019 | 187 | 0.150 |
Why?
|
| Principal Component Analysis | 2 | 2012 | 947 | 0.150 |
Why?
|
| Menstrual Cycle | 1 | 2001 | 539 | 0.140 |
Why?
|
| Conditioning, Operant | 1 | 2019 | 306 | 0.140 |
Why?
|
| Paroxetine | 3 | 2003 | 181 | 0.140 |
Why?
|
| Disease Models, Animal | 8 | 2019 | 18292 | 0.140 |
Why?
|
| Australia | 1 | 2021 | 1260 | 0.140 |
Why?
|
| Phosphorus Isotopes | 1 | 2017 | 125 | 0.140 |
Why?
|
| Neuroimmunomodulation | 1 | 2019 | 186 | 0.140 |
Why?
|
| HIV-1 | 3 | 2022 | 6945 | 0.140 |
Why?
|
| Mice, Transgenic | 5 | 2022 | 9541 | 0.140 |
Why?
|
| Brazil | 1 | 2021 | 1248 | 0.140 |
Why?
|
| Amygdala | 2 | 2015 | 1376 | 0.140 |
Why?
|
| Blood Cells | 1 | 1998 | 307 | 0.130 |
Why?
|
| Dibutyryl Cyclic GMP | 1 | 1996 | 6 | 0.130 |
Why?
|
| Photic Stimulation | 3 | 2019 | 1992 | 0.130 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2014 | 4627 | 0.130 |
Why?
|
| Mice | 10 | 2023 | 81782 | 0.130 |
Why?
|
| Random Allocation | 2 | 2019 | 2394 | 0.130 |
Why?
|
| Central Nervous System Stimulants | 1 | 2004 | 1166 | 0.130 |
Why?
|
| AIDS Dementia Complex | 2 | 2012 | 154 | 0.130 |
Why?
|
| Second Messenger Systems | 2 | 1996 | 203 | 0.130 |
Why?
|
| Steroids | 1 | 2021 | 934 | 0.130 |
Why?
|
| Nitroprusside | 1 | 1996 | 271 | 0.130 |
Why?
|
| Hypogonadism | 2 | 2019 | 801 | 0.130 |
Why?
|
| Executive Function | 1 | 2024 | 1391 | 0.130 |
Why?
|
| Image Enhancement | 2 | 2004 | 2857 | 0.130 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2013 | 618 | 0.130 |
Why?
|
| Emotions | 3 | 2014 | 2759 | 0.120 |
Why?
|
| Tritium | 5 | 1994 | 702 | 0.120 |
Why?
|
| Female | 41 | 2021 | 396141 | 0.120 |
Why?
|
| Mazindol | 1 | 1994 | 13 | 0.120 |
Why?
|
| Cerebral Cortex | 3 | 2010 | 5765 | 0.120 |
Why?
|
| Seasons | 1 | 2021 | 1522 | 0.120 |
Why?
|
| Checklist | 1 | 2022 | 837 | 0.120 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2014 | 40 | 0.120 |
Why?
|
| Violence | 1 | 2021 | 931 | 0.120 |
Why?
|
| Tomography, Emission-Computed | 3 | 1998 | 1006 | 0.120 |
Why?
|
| Macaca mulatta | 2 | 2019 | 2341 | 0.110 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2020 | 1139 | 0.110 |
Why?
|
| Fluoxetine | 3 | 2003 | 731 | 0.110 |
Why?
|
| Racemases and Epimerases | 1 | 2014 | 113 | 0.110 |
Why?
|
| Neurons | 1 | 2013 | 9527 | 0.110 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2012 | 564 | 0.110 |
Why?
|
| Septum Pellucidum | 1 | 2013 | 55 | 0.110 |
Why?
|
| Simian immunodeficiency virus | 1 | 2019 | 812 | 0.110 |
Why?
|
| Psychotropic Drugs | 1 | 2019 | 880 | 0.110 |
Why?
|
| Cyclic GMP | 1 | 1995 | 394 | 0.110 |
Why?
|
| Benzeneacetamides | 1 | 2013 | 36 | 0.110 |
Why?
|
| Analysis of Variance | 4 | 2011 | 6202 | 0.110 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2013 | 101 | 0.100 |
Why?
|
| Laboratory Animal Science | 1 | 2012 | 9 | 0.100 |
Why?
|
| Spleen | 1 | 1998 | 2294 | 0.100 |
Why?
|
| Reward | 1 | 2019 | 980 | 0.100 |
Why?
|
| Carrier Proteins | 4 | 1998 | 4909 | 0.100 |
Why?
|
| Tetracycline | 1 | 2012 | 216 | 0.100 |
Why?
|
| Regional Blood Flow | 3 | 2004 | 1479 | 0.100 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2013 | 133 | 0.100 |
Why?
|
| Glutamine | 1 | 2015 | 574 | 0.100 |
Why?
|
| Temperature | 1 | 2019 | 2226 | 0.100 |
Why?
|
| Receptors, Opioid, mu | 1 | 2013 | 165 | 0.100 |
Why?
|
| Middle Aged | 16 | 2024 | 223016 | 0.100 |
Why?
|
| Conditioning, Classical | 1 | 2014 | 368 | 0.090 |
Why?
|
| Restraint, Physical | 1 | 2013 | 185 | 0.090 |
Why?
|
| Aging | 3 | 2022 | 8725 | 0.090 |
Why?
|
| Temporal Lobe | 3 | 2010 | 1715 | 0.090 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 2233 | 0.090 |
Why?
|
| Cerebrovascular Disorders | 1 | 1998 | 1475 | 0.090 |
Why?
|
| Case-Control Studies | 5 | 2017 | 22228 | 0.090 |
Why?
|
| Stroop Test | 1 | 2010 | 71 | 0.090 |
Why?
|
| Administration, Oral | 3 | 2009 | 4016 | 0.090 |
Why?
|
| Rats, Inbred WKY | 1 | 2010 | 150 | 0.090 |
Why?
|
| Hematocrit | 3 | 2001 | 622 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2022 | 1966 | 0.090 |
Why?
|
| Rats, Inbred SHR | 1 | 2010 | 189 | 0.090 |
Why?
|
| Fentanyl | 1 | 2013 | 451 | 0.080 |
Why?
|
| Injections, Intramuscular | 1 | 2011 | 551 | 0.080 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2011 | 434 | 0.080 |
Why?
|
| Nicotinic Agonists | 1 | 2011 | 265 | 0.080 |
Why?
|
| Heterocyclic Compounds | 3 | 2001 | 245 | 0.080 |
Why?
|
| Administration, Cutaneous | 1 | 2011 | 712 | 0.080 |
Why?
|
| Internal-External Control | 1 | 2010 | 348 | 0.080 |
Why?
|
| Tissue Distribution | 4 | 1994 | 2270 | 0.080 |
Why?
|
| Corpus Striatum | 2 | 1993 | 1218 | 0.080 |
Why?
|
| Depressive Disorder, Major | 2 | 2003 | 4805 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2010 | 6013 | 0.080 |
Why?
|
| Models, Animal | 1 | 2015 | 2120 | 0.080 |
Why?
|
| Parietal Lobe | 2 | 2012 | 859 | 0.070 |
Why?
|
| Behavior, Animal | 2 | 2014 | 1866 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2019 | 8279 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2019 | 3140 | 0.070 |
Why?
|
| Occipital Lobe | 1 | 2009 | 376 | 0.070 |
Why?
|
| Psychological Tests | 1 | 2009 | 642 | 0.070 |
Why?
|
| Schizophrenia | 2 | 2017 | 6971 | 0.070 |
Why?
|
| Rest | 1 | 2012 | 940 | 0.070 |
Why?
|
| Hippocampus | 2 | 2022 | 3772 | 0.070 |
Why?
|
| Organometallic Compounds | 3 | 2001 | 645 | 0.070 |
Why?
|
| Postmortem Changes | 1 | 2006 | 119 | 0.070 |
Why?
|
| Nicotine | 1 | 2011 | 680 | 0.060 |
Why?
|
| Brain Damage, Chronic | 1 | 2007 | 265 | 0.060 |
Why?
|
| Wakefulness | 1 | 2013 | 1282 | 0.060 |
Why?
|
| Quinolines | 1 | 2011 | 769 | 0.060 |
Why?
|
| Time Factors | 9 | 2011 | 40097 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 2307 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2013 | 1404 | 0.060 |
Why?
|
| Carbon Isotopes | 1 | 2006 | 451 | 0.060 |
Why?
|
| Regression Analysis | 3 | 2012 | 6321 | 0.060 |
Why?
|
| Affect | 3 | 2004 | 1494 | 0.060 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 1987 | 0.060 |
Why?
|
| Hydrocortisone | 1 | 2013 | 1832 | 0.060 |
Why?
|
| Public Health | 1 | 2018 | 2680 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2805 | 0.060 |
Why?
|
| Astrocytes | 1 | 2012 | 1346 | 0.060 |
Why?
|
| Memory Disorders | 1 | 2011 | 1193 | 0.060 |
Why?
|
| Double-Blind Method | 8 | 2019 | 12417 | 0.060 |
Why?
|
| Protons | 1 | 2009 | 1073 | 0.060 |
Why?
|
| Psychotic Disorders | 1 | 2019 | 3274 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 8107 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2016 | 8724 | 0.050 |
Why?
|
| Dominance, Cerebral | 1 | 2004 | 616 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2005 | 3360 | 0.050 |
Why?
|
| Heart Rate | 4 | 2004 | 4203 | 0.050 |
Why?
|
| Echo-Planar Imaging | 2 | 1998 | 649 | 0.050 |
Why?
|
| Phospholipids | 2 | 2004 | 776 | 0.050 |
Why?
|
| Substance Abuse Detection | 1 | 2004 | 301 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14643 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 5784 | 0.050 |
Why?
|
| Hemodilution | 1 | 2001 | 120 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 22327 | 0.050 |
Why?
|
| Rats | 3 | 2014 | 23708 | 0.050 |
Why?
|
| Clathrin | 1 | 2022 | 259 | 0.040 |
Why?
|
| Contrast Media | 5 | 2004 | 5330 | 0.040 |
Why?
|
| Progesterone | 2 | 2022 | 751 | 0.040 |
Why?
|
| Gadolinium | 3 | 2001 | 966 | 0.040 |
Why?
|
| Fluorine | 1 | 2000 | 78 | 0.040 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2022 | 140 | 0.040 |
Why?
|
| Marijuana Abuse | 1 | 2004 | 409 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 5128 | 0.040 |
Why?
|
| Alleles | 1 | 2011 | 6891 | 0.040 |
Why?
|
| Water-Electrolyte Balance | 1 | 2000 | 326 | 0.040 |
Why?
|
| Follicular Phase | 1 | 1999 | 143 | 0.040 |
Why?
|
| Inflammation | 1 | 2019 | 10843 | 0.040 |
Why?
|
| Luteal Phase | 1 | 1999 | 138 | 0.040 |
Why?
|
| Sex Factors | 2 | 2004 | 10611 | 0.040 |
Why?
|
| Recurrence | 1 | 2011 | 8492 | 0.040 |
Why?
|
| Polycythemia | 1 | 1999 | 124 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2000 | 507 | 0.040 |
Why?
|
| Synaptic Transmission | 1 | 2004 | 1178 | 0.040 |
Why?
|
| Alprazolam | 1 | 1998 | 103 | 0.040 |
Why?
|
| Thalamus | 1 | 2004 | 1048 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 2001 | 0.040 |
Why?
|
| Crack Cocaine | 1 | 1998 | 33 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2022 | 606 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2022 | 893 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2013 | 4527 | 0.040 |
Why?
|
| Estradiol | 2 | 2022 | 1947 | 0.040 |
Why?
|
| Blood Pressure | 3 | 2004 | 8530 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 8722 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2001 | 1587 | 0.040 |
Why?
|
| Parkinson Disease | 1 | 1991 | 2885 | 0.040 |
Why?
|
| Syndrome | 1 | 2003 | 3271 | 0.030 |
Why?
|
| Morbidity | 1 | 2022 | 1752 | 0.030 |
Why?
|
| Receptors, Dopamine D1 | 1 | 1998 | 276 | 0.030 |
Why?
|
| Neurosecretory Systems | 1 | 2018 | 223 | 0.030 |
Why?
|
| Risk Factors | 2 | 2019 | 74850 | 0.030 |
Why?
|
| Neuropsychology | 1 | 1997 | 110 | 0.030 |
Why?
|
| Hemoglobins | 2 | 1999 | 1531 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2004 | 1429 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2011 | 65194 | 0.030 |
Why?
|
| Anti-Anxiety Agents | 1 | 1998 | 403 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 1999 | 681 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2022 | 863 | 0.030 |
Why?
|
| Spiperone | 1 | 1995 | 31 | 0.030 |
Why?
|
| Ketanserin | 1 | 1995 | 24 | 0.030 |
Why?
|
| Swine | 2 | 1996 | 5986 | 0.030 |
Why?
|
| Mianserin | 1 | 1995 | 51 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2019 | 1751 | 0.030 |
Why?
|
| Drug Tolerance | 1 | 1996 | 365 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 1998 | 1143 | 0.030 |
Why?
|
| Reference Values | 3 | 2001 | 4909 | 0.030 |
Why?
|
| Analgesics | 1 | 2020 | 1057 | 0.030 |
Why?
|
| Papio | 1 | 1995 | 671 | 0.030 |
Why?
|
| Binding Sites | 2 | 1992 | 5999 | 0.030 |
Why?
|
| Iodine Radioisotopes | 2 | 1998 | 1029 | 0.030 |
Why?
|
| United States | 1 | 2021 | 72909 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 1998 | 1028 | 0.030 |
Why?
|
| Cerebral Angiography | 1 | 1998 | 1262 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 16039 | 0.020 |
Why?
|
| Testosterone | 1 | 2022 | 2495 | 0.020 |
Why?
|
| HIV Seropositivity | 1 | 1997 | 961 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 26282 | 0.020 |
Why?
|
| Hemodynamics | 2 | 1998 | 4186 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2011 | 271 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 1997 | 1408 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 2045 | 0.020 |
Why?
|
| Hypertension | 1 | 2010 | 8616 | 0.020 |
Why?
|
| Maze Learning | 1 | 2011 | 482 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2006 | 6542 | 0.020 |
Why?
|
| Comorbidity | 1 | 2004 | 10575 | 0.020 |
Why?
|
| Cattle | 1 | 1995 | 3801 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 6306 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 20133 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2001 | 6409 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2000 | 3712 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1998 | 3690 | 0.020 |
Why?
|
| Age of Onset | 1 | 2013 | 3343 | 0.020 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2007 | 165 | 0.020 |
Why?
|
| Serotonin | 1 | 1990 | 1046 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 1990 | 1207 | 0.020 |
Why?
|
| Thrombosis | 1 | 1999 | 2955 | 0.020 |
Why?
|
| Anxiety | 1 | 2020 | 4669 | 0.020 |
Why?
|
| Auditory Threshold | 1 | 1987 | 369 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2011 | 1470 | 0.020 |
Why?
|
| Trachea | 1 | 1990 | 1091 | 0.010 |
Why?
|
| Noise | 1 | 1987 | 296 | 0.010 |
Why?
|
| Research Design | 1 | 2000 | 6204 | 0.010 |
Why?
|
| Carbon Monoxide | 1 | 1987 | 560 | 0.010 |
Why?
|
| Calcium | 1 | 1996 | 5769 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18382 | 0.010 |
Why?
|
| Atrophy | 1 | 2007 | 1629 | 0.010 |
Why?
|
| Functional Laterality | 2 | 1998 | 2243 | 0.010 |
Why?
|
| Risk | 1 | 2013 | 9599 | 0.010 |
Why?
|
| Learning | 1 | 2010 | 1754 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1999 | 157 | 0.010 |
Why?
|
| Blood Viscosity | 1 | 1999 | 125 | 0.010 |
Why?
|
| Aged | 3 | 2006 | 171163 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 4851 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 1882 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 2350 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2000 | 39228 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2018 | 6870 | 0.010 |
Why?
|
| Axons | 1 | 2005 | 1678 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 41680 | 0.010 |
Why?
|
| Adolescent | 3 | 2013 | 88811 | 0.010 |
Why?
|
| Placebos | 1 | 2000 | 1659 | 0.010 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 1998 | 410 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2000 | 2227 | 0.010 |
Why?
|
| Acetazolamide | 1 | 1995 | 98 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2010 | 3719 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1998 | 1377 | 0.010 |
Why?
|
| Phosphates | 1 | 1996 | 763 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15645 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 1998 | 2108 | 0.010 |
Why?
|
| Ligands | 1 | 1998 | 3272 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1995 | 988 | 0.010 |
Why?
|
| Hexamethonium Compounds | 1 | 1990 | 23 | 0.010 |
Why?
|
| Hexamethonium | 1 | 1990 | 16 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 59857 | 0.010 |
Why?
|
| Atropine | 1 | 1990 | 242 | 0.010 |
Why?
|
| Serotonin Antagonists | 1 | 1990 | 146 | 0.010 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 1990 | 201 | 0.010 |
Why?
|
| Capsaicin | 1 | 1990 | 226 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1990 | 1300 | 0.000 |
Why?
|
| Sex Characteristics | 1 | 1999 | 2645 | 0.000 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1990 | 1056 | 0.000 |
Why?
|
| Binding, Competitive | 1 | 1990 | 1140 | 0.000 |
Why?
|
| Acetylcholine | 1 | 1990 | 628 | 0.000 |
Why?
|
| Brain Diseases | 1 | 1997 | 1552 | 0.000 |
Why?
|
| Audiometry, Pure-Tone | 1 | 1987 | 210 | 0.000 |
Why?
|
| Protein Kinase C | 1 | 1990 | 1202 | 0.000 |
Why?
|
| Epithelium | 1 | 1990 | 1603 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1987 | 2077 | 0.000 |
Why?
|
| Models, Biological | 1 | 2001 | 9443 | 0.000 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 1987 | 144 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1990 | 3945 | 0.000 |
Why?
|
| Body Mass Index | 1 | 1999 | 13042 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1990 | 13398 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1990 | 17596 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1995 | 59496 | 0.000 |
Why?
|